MENU
SGMT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Sagimet Biosciences (SGMT) Earnings Date & Reports

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways... Show more

A.I. Advisor
published Earnings

SGMT is expected to report earnings to rise 42.00% to -70 cents per share on May 14

Sagimet Biosciences SGMT Stock Earnings Reports
Q1'25
Est.
$-0.71
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.10
Q2'24
Beat
by $0.25
Q1'24
Beat
by $0.24
The last earnings report on March 12 showed earnings per share of -50 cents, missing the estimate of -49 cents. With 416.12K shares outstanding, the current market capitalization sits at 89.50M.
View a ticker or compare two or three
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
155 Bovet Road
Phone
+1 650 561-8600
Employees
10
Web
https://www.sagimet.com